Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
中
中

Media

 >  Media
 >  Video
Company News
Media Releases
Video

Video

How our first-in-class GKA sends T2D patients into diabetes remission

Jan 03, 2024

历经十年 全球首创糖尿病新药在上海张江诞生|财经夜行线

Oct 17, 2022

兑现十年承诺，上海研发全球首创糖尿病新药领证投产

Oct 16, 2022

上海：全球首创糖尿病新药开始投产

Oct 15, 2022

上市获批仅一周 全球首创糖尿病新药启动生产

Oct 15, 2022

“张江研发”十年磨一剑 全球首创糖尿病新药获批上市

Oct 09, 2022

“张江研发”十年一剑 全球首创糖尿病新药获批上市

Oct 09, 2022

AI医疗：新发现 新场景 加速度丨元空间大放送

Sep 02, 2022

更高水平开放

Aug 12, 2022

全球首创糖尿病新药临床研究新成果发布 可改善餐后血糖波动性 安全及耐受性良好

May 15, 2022

皇冠体育 ADA TV 系列短片（第一部分）

Oct 18, 2019

皇冠体育 ADA TV 系列短片（第二部分）

Oct 18, 2019
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Senior Scientific Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Dorzagliatin
mGluR5
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
HuaTangNing(华堂宁®)
Focus Us
Copyright © 2024  Hua Medicine (Shanghai) Co., Ltd.    互联网药品信息服务资格证书编号: （沪）-非经营-2022-0079
沪ICP备14036654号-1  beiantubiao.png 沪公网安备 31011502013809号  Privacy Statement  Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.
Accept
x